Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol

INTRODUCTION: Delayed cerebral ischaemia (DCI) due to cerebral vasospasm (cVS) remains the foremost contributor to morbidity and mortality following aneurysmal subarachnoid haemorrhage (aSAH). Past efforts in preventing and treating DCI have failed to make any significant progress. To date, our most...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawley, Troy, Claus, Chad F, Tong, Doris, Rajamand, Sina, Sigler, Diana, Bahoura, Matthew, Garmo, Lucas, Soo, Teck M, Kelkar, Prashant, Richards, Boyd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537439/
https://www.ncbi.nlm.nih.gov/pubmed/33020083
http://dx.doi.org/10.1136/bmjopen-2019-036217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537439/
https://www.ncbi.nlm.nih.gov/pubmed/33020083
http://dx.doi.org/10.1136/bmjopen-2019-036217

Ejemplares similares